Metabolic profiles identify circulating biomarkers associated with heart failure in young single ventricle patients

被引:8
作者
O'Connell, Thomas M. [1 ,2 ,3 ]
Logsdon, David L. [2 ,3 ]
Mitscher, Gloria [4 ,5 ]
Payne, R. Mark [4 ,5 ]
机构
[1] Indiana Univ Sch Med, Dept Otolaryngol Head & Neck Surg, 1300 W Michigan St,Suite 400, Indianapolis, IN 46202 USA
[2] Indiana Univ Sch Med, Dept Anat Cell Biol & Physiol, Indianapolis, IN 46202 USA
[3] Indiana Univ Sch Med, Indiana Ctr Musculoskeletal Hlth, Indianapolis, IN 46202 USA
[4] Indiana Univ Sch Med, Dept Pediat, Div Cardiol, Indianapolis, IN 46202 USA
[5] Indiana Univ Sch Med, Dept Pediat, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA
关键词
Single ventricle; Metabolomics; Heart failure; Biomarker; Children; LONG-TERM OUTCOMES; BILE-ACIDS; FOLLOW-UP; DISEASE; CHILDREN; SERUM; RISK;
D O I
10.1007/s11306-021-01846-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Children and young adults with single ventricle (SV) heart disease frequently develop heart failure (HF) that is intractable and difficult to treat. Our understanding of the molecular and biochemical reasons underlying this is imperfect. Thus, there is an urgent need for biomarkers that predict outcome and provide a rational basis for treatment, and advance our understanding of the basis of HF. Objective We sought to determine if a metabolomic approach would provide biochemical signatures of HF in SV children and young adults. If significant, these analytes might serve as biomarkers to predict outcome and inform on the biological mechanism(s) of HF. Methods We applied a multi-platform metabolomics approach composed of mass spectrometry (MS) and nuclear magnetic resonance (NMR) which yielded 495 and 26 metabolite measurements respectively. The plasma samples came from a cross-sectional set of young SV subjects, ages 2-19 years with ten control (Con) subjects and 16 SV subjects. Of the SV subjects, nine were diagnosed as congestive HF (SVHF), and 7 were not in HF. Metabolomic data were correlated with clinical status to determine if there was a signature associated with HF. Results There were no differences in age, height, weight or sex between the 3 cohorts. However, statistical analysis of the metabolomic profiles using ANOVA revealed 44 metabolites with significant differences between cohorts including 41 profiled by MS and 3 by NMR. These metabolites included acylcarnitines, amino acids, and bile acids, which distinguished Con from all SV subjects. Furthermore, metabolite profiles could distinguish between SV and SVHF subjects. Conclusion These are the first data to demonstrate a clear metabolomic signature associated with HF in children and young adults with SV. Larger studies are warranted to determine if these findings are predictive of progression to HF in time to provide intervention.
引用
收藏
页数:10
相关论文
共 29 条
  • [1] Longitudinal Outcomes of Patients With Single Ventricle After the Fontan Procedure
    Atz, Andrew M.
    Zak, Victor
    Mahony, Lynn
    Uzark, Karen
    D'agincourt, Nicholas
    Goldberg, David J.
    Williams, Richard V.
    Breitbart, Roger E.
    Colan, Steven D.
    Burns, Kristin M.
    Margossian, Renee
    Henderson, Heather T.
    Korsin, Rosalind
    Marino, Bradley S.
    Daniels, Kaitlyn
    McCrindle, Brian W.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (22) : 2735 - 2744
  • [2] Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts
    Beckonert, Olaf
    Keun, Hector C.
    Ebbels, Timothy M. D.
    Bundy, Jacob G.
    Holmes, Elaine
    Lindon, John C.
    Nicholson, Jeremy K.
    [J]. NATURE PROTOCOLS, 2007, 2 (11) : 2692 - 2703
  • [3] Choudhury Roni, 2020, J Open Source Softw, V5, DOI 10.21105/joss.02410
  • [4] The New York University Pediatric Heart Failure Index: A new method of quantifying chronic heart failure severity in children
    Connolly, D
    Rutkowski, M
    Auslender, M
    Arlman, M
    [J]. JOURNAL OF PEDIATRICS, 2001, 138 (05) : 644 - 648
  • [5] Redefining Expectations of Long-Term Survival After the Fontan Procedure Twenty-Five Years of Follow-Up From the Entire Population of Australia and New Zealand
    d'Udekem, Yves
    Iyengar, Ajay J.
    Galati, John C.
    Forsdick, Victoria
    Weintraub, Robert G.
    Wheaton, Gavin R.
    Bullock, Andrew
    Justo, Robert N.
    Grigg, Leeanne E.
    Sholler, Gary F.
    Hope, Sarah
    Radford, Dorothy J.
    Gentles, Thomas L.
    Celermajer, David S.
    Winlaw, David S.
    [J]. CIRCULATION, 2014, 130 (11) : S32 - S38
  • [6] Fontan-Associated Liver Disease Screening, Management, and Transplant Considerations
    Emamaullee, Juliet
    Zaidi, Ali N.
    Schiano, Thomas
    Kahn, Jeffrey
    Valentino, Pamela L.
    Hofer, Ryan E.
    Taner, Timucin
    Wald, Joyce W.
    Olthoff, Kim M.
    Bucuvalas, John
    Fischer, Ryan
    [J]. CIRCULATION, 2020, 142 (06) : 591 - 604
  • [7] Survival in patients with univentricular hearts: the impact of right versus left ventricular morphology
    Erikssen, Gunnar
    Aboulhosn, Jamil
    Lin, Jeannette
    Liestol, Knut
    Estensen, Mette E.
    Gjesdal, Ola
    Skulstad, Helge
    Dohlen, Gaute
    Lindberg, Harald Lauritz
    [J]. OPEN HEART, 2018, 5 (02):
  • [8] The Fontan Procedure: Anatomy, Complications, and Manifestations of Failure
    Fredenburg, Tyler B.
    Johnson, Tiffanie R.
    Cohen, Mervyn D.
    [J]. RADIOGRAPHICS, 2011, 31 (02) : 453 - U193
  • [9] The incidence of congenital heart disease
    Hoffman, JIE
    Kaplan, S
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (12) : 1890 - 1900
  • [10] Heart Failure in Children Part I: History, Etiology, and Pathophysiology
    Hsu, Daphne T.
    Pearson, Gail D.
    [J]. CIRCULATION-HEART FAILURE, 2009, 2 (01) : 63 - 70